Fentanyl inhibits metabolism of midazolam: competitive inhibition of CYP3A4 in vitro |
| |
Authors: | Oda Y Mizutani K Hase I Nakamoto T Hamaoka N Asada A |
| |
Institution: | Department of Anesthesiology and Intensive Care Medicine, Osaka City University Medical School, 1-5-7 Asahimachi, Abeno-ku, Osaka 545-8585, Japan |
| |
Abstract: | Fentanyl decreases clearance of midazolam administered i.v., but the
mechanism remains unclear. To elucidate this mechanism, we have
investigated the effect of fentanyl on metabolism of midazolam using human
hepatic microsomes and recombinant cytochrome P450 isoforms (n = 6).
Midazolam was metabolized to l'-hydroxymidazolam (l'-OH MDZ) by human
hepatic microsomes, with a Michaelis-Menten constant (K(m)) of 5.0 (SD 2.7)
microgramsmol litre-1. Fentanyl competitively inhibited metabolism of
midazolam in human hepatic microsomes, with an inhibition constant (Ki) of
26.8 (12.4) microgramsmol litre-1. Of the seven representative human
hepatic P450 isoforms, CYP1A2, 2A6, 2C9, 2C19, 2D6, 2E1 and 3A4, only
CYP3A4 catalysed hydroxylation of midazolam, with a K(m) of 3.6 (0.8)
microgramsmol liter-1. Fentanyl competitively inhibited metabolism of
midazolam to l'-OH MDZ by CYP3A4, with a Ki of 24.2 (6.8) microgramsmol
litre-1, comparable with the Ki obtained in human hepatic microsomes. These
findings indicate that fentanyl competitively inhibits metabolism of
midazolam by CYP3A4.
|
| |
Keywords: | |
本文献已被 PubMed Oxford 等数据库收录! |
|